Uncategorized files

Showing below up to 50 results in range #47,391 to #47,440.

• 
  Peganone 01 STructure.png 442 × 192; 17 KB
  
• 
  Peganone 02 Warnings.png 557 × 383; 25 KB
  
• 
  Peganone 03.jpg 705 × 241; 50 KB
  
• 
  Pegaptanib CS Fig 1.png 614 × 293; 34 KB
  
• 
  Pegaptanib CS Fig 2.png 620 × 259; 64 KB
  
• 
  Pegaptanib Dosage.png 503 × 525; 132 KB
  
• 
  Pegaptanib Ing and App.png 615 × 983; 91 KB
  
• 
  Pegaptanib PDP.png 647 × 282; 149 KB
  
• 
  Pegaptanib Str.png 639 × 522; 260 KB
  
• 
  Pegaptanib Wiki Str.png 309 × 261; 10 KB
  
• 
  Pegaspargase Package1.png 642 × 453; 297 KB
  
• 
  Pegaspargase ppearance.png 600 × 1,178; 92 KB
  
• 
  Pegasparginase AR1.png 649 × 605; 68 KB
  
• 
  Pegasparginase AR2.png 625 × 375; 42 KB
  
• 
  Pegaspergase CS1.png 627 × 536; 82 KB
  
• 
  Pegfilgrastim image.jpg 1,011 × 334; 69 KB
  
• 
  Pegfilgrastim ingredients and appearance.png 629 × 1,321; 114 KB
  
• 
  Pegfilgrastim label01.png 1,122 × 376; 354 KB
  
• 
  Pegfilgrastim patient counseling information.png 600 × 3,909; 916 KB
  
• 
  Pegfilgrastim table01.png 466 × 212; 8 KB
  
• 
  Peginterferon alfa-2a 135 ug-0.5 ml.png 396 × 743; 226 KB
  
• 
  Peginterferon alfa-2a 135 ug-0.5 ml FDA package label.png 622 × 1,093; 98 KB
  
• 
  Peginterferon alfa-2a 180 ug-0.5 ml.png 448 × 262; 119 KB
  
• 
  Peginterferon alfa-2a 180 ug-0.5 ml FDA package label.png 623 × 1,022; 89 KB
  
• 
  Peginterferon alfa-2a 180 ug-1 ml.png 214 × 294; 81 KB
  
• 
  Peginterferon alfa-2a 180 ug-1 ml FDA package label.png 629 × 1,001; 86 KB
  
• 
  Peginterferon alfa-2a Adverse reactions adult patients.png 497 × 2,840; 236 KB
  
• 
  Peginterferon alfa-2a Adverse reactions pediatric patients.png 492 × 1,106; 99 KB
  
• 
  Peginterferon alfa-2a Percentage of Subjects with Serological, Virological, Biochemical, and Histological Response.png 620 × 907; 99 KB
  
• 
  Peginterferon alfa-2a Selected Hematologic Abnormalities.png 613 × 610; 64 KB
  
• 
  Peginterferon alfa-2a Sustained Response to Monotherapy Treatment.png 1,520 × 285; 62 KB
  
• 
  Peginterferon alfa-2a Sustained Virologic Response as a Function of Genotype.png 486 × 385; 48 KB
  
• 
  Peginterferon alfa-2a Sustained Virologic Response in Pediatric Subjects.png 502 × 404; 50 KB
  
• 
  Peginterferon alfa-2a Sustained Virologic Response in Subjects with Chronic Hepatitis C Coinfected with HIV.png 489 × 300; 34 KB
  
• 
  Peginterferon alfa-2a Sustained Virologic Response to Combination Therapy.png 548 × 263; 41 KB
  
• 
  Pegloticase01.png 504 × 578; 50 KB
  
• 
  Pegloticase02.png 499 × 796; 74 KB
  
• 
  Pegloticase03.png 618 × 2,611; 278 KB
  
• 
  Pegloticase04.png 622 × 477; 155 KB
  
• 
  Pegloticase05.png 604 × 1,312; 78 KB
  
• 
  Pegvaliaseclinexp.png 175 × 833; 180 KB
  
• 
  Pegvaliasedosage1.png 415 × 571; 89 KB
  
• 
  Pegvaliaselabel1.jpeg 676 × 529; 74 KB
  
• 
  Pegvaliaselabel10.jpeg 1,116 × 876; 109 KB
  
• 
  Pegvaliaselabel2.jpeg 650 × 218; 37 KB
  
• 
  Pegvaliaselabel3.jpeg 291 × 253; 18 KB
  
• 
  Pegvaliaselabel4.jpeg 678 × 534; 72 KB
  
• 
  Pegvaliaselabel5.jpeg 662 × 217; 36 KB
  
• 
  Pegvaliaselabel6.jpeg 295 × 257; 18 KB
  
• 
  Pegvaliaselabel7.jpeg 674 × 515; 73 KB